Asset Management One Co. Ltd. trimmed its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 5.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 465,918 shares of the real estate investment trust's stock after selling 26,651 shares during the period. Asset Management One Co. Ltd. owned 0.20% of Sabra Healthcare REIT worth $8,140,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also bought and sold shares of the company. Harbor Capital Advisors Inc. lifted its stake in shares of Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after buying an additional 642 shares in the last quarter. Assetmark Inc. raised its holdings in Sabra Healthcare REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after acquiring an additional 656 shares during the period. Focus Partners Wealth raised its holdings in Sabra Healthcare REIT by 4.0% during the 4th quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust's stock valued at $360,000 after acquiring an additional 797 shares during the period. Oregon Public Employees Retirement Fund lifted its position in shares of Sabra Healthcare REIT by 1.7% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 48,185 shares of the real estate investment trust's stock worth $835,000 after acquiring an additional 800 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its position in shares of Sabra Healthcare REIT by 1.4% during the first quarter. QRG Capital Management Inc. now owns 60,796 shares of the real estate investment trust's stock worth $1,062,000 after acquiring an additional 813 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Sabra Healthcare REIT
In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director owned 64,725 shares of the company's stock, valued at $1,179,289.50. This represents a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.10% of the company's stock.
Sabra Healthcare REIT Price Performance
Shares of SBRA traded down $0.14 during trading hours on Tuesday, reaching $18.30. 2,221,567 shares of the company's stock traded hands, compared to its average volume of 2,292,031. Sabra Healthcare REIT, Inc. has a 12 month low of $15.11 and a 12 month high of $20.03. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. The stock has a market cap of $4.35 billion, a PE ratio of 31.02, a price-to-earnings-growth ratio of 1.39 and a beta of 0.85. The firm's 50 day simple moving average is $17.85 and its 200-day simple moving average is $17.29.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business had revenue of $183.54 million for the quarter, compared to the consensus estimate of $180.23 million. During the same period last year, the firm posted $0.35 earnings per share. Sabra Healthcare REIT's quarterly revenue was up 10.1% on a year-over-year basis. Equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Friday, May 16th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.56%. The ex-dividend date was Friday, May 16th. Sabra Healthcare REIT's dividend payout ratio is currently 203.39%.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Truist Financial boosted their price objective on Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Scotiabank increased their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $19.67.
Read Our Latest Analysis on SBRA
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.